| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 1.02 Billion | USD 3.54 Billion | 13.20% | 2024 |
FrequentlyAsked Questions
Lung cancer liquid biopsy is a new and advanced way to detect cancer by studying cancer-related markers found in the blood, instead of doing painful tissue biopsies.
The lung cancer liquid biopsy market is expected to be driven by increasing lung cancer prevalence, growing demand for non-invasive diagnostic methods, expanding applications in precision medicine, technological advancements in molecular diagnostics, and rising acceptance of liquid biopsy as a standard care tool.
According to our study, the global lung cancer liquid biopsy market was worth around USD 1.02 billion in 2024 and is predicted to grow to around USD 3.54 billion by 2034.
The CAGR value of the lung cancer liquid biopsy market is expected to be around 13.20% during 2025-2034.
The global lung cancer liquid biopsy market will register the highest revenue contribution from North America during the forecast period.
Key players in the lung cancer liquid biopsy market include Guardant Health Inc., Roche Diagnostics Ltd., Illumina Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Bio-Rad Laboratories Inc., Sysmex Corporation, Exact Sciences Corporation, Natera Inc., Foundation Medicine Inc., Personalis Inc., NeoGenomics Laboratories Inc., Biocept Inc., MDxHealth SA, and Epigenomics AG.
The report provides a comprehensive analysis of the lung cancer liquid biopsy market, including an in-depth examination of market drivers, restraints, emerging trends, regional dynamics, and future growth prospects. It also examines the competitive dynamics, technology innovations, distribution strategies, and clinical applications that shape the modern healthcare and biotechnology ecosystem.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.

Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed